1. The Department shall encourage each provider of health care or other services who:
(a) Is qualified to conduct blood tests during the course of his or her practice to perform, or cause to be performed, a test to determine the amount of lead in the blood of each child receiving services from the provider of health care or other services when the child:
(1) Reaches 12 and 24 months of age, respectively; or
(2) At least once before the child reaches 6 years of age.
(b) Provides early and periodic screening, diagnostic and treatment services to a child in accordance with 42 U.S.C. §§ 1396 et seq. to conduct, or cause to be conducted, a screening for the amount of lead in the blood of the child in accordance with the guidelines of the Centers for Medicare and Medicaid Services of the United States Department of Health and Human Services.
2. Any result of a blood test specified in subsection 1 which is obtained by using a capillary specimen and which indicates an amount of lead in the blood that is greater than the amount designated by the Council of State and Territorial Epidemiologists or, if that organization ceases to exist, an organization designated by regulation of the State Board of Health, as indicating an elevated amount of lead must, as soon as practicable after the result is obtained, be confirmed by a second test using a sample of blood from a vein of the child.
3. Each qualified laboratory, office of a provider of health care or other services or medical facility that conducts a blood test for the presence of lead in a child who is under 18 years of age shall, as soon as practicable after conducting the test, submit a report of the results of the test to the appropriate health authority in accordance with regulations adopted by the State Board of Health. The report must include, without limitation:
(a) The name, sex, race, ethnicity and date of birth of the child;
(b) The address of the child, including, without limitation, the county and zip code in which the child resides;
(c) The date on which the sample was collected;
(d) The type of sample that was collected; and
(e) The name and contact information of the provider of health care who ordered the test.
4. As used in this section:
(a) "Health authority" has the meaning ascribed to it in NRS 441A.050.
(b) "Medical facility" has the meaning ascribed to it in NRS 449.0151.
(Added to NRS by 2009, 457; A 2019, 3041)